HAVCR2 and neoplasm: Tumors implanted in CEACAM1 deficient mice exhibited impaired growth rate and mouse anti-CEACAM1 Ab CC1 prevented tumor growth in combination with anti-PD-L1 or anti-TIM-3 mAbs [21].